menu

Lyfe Bulb

 1,045

J.P. Morgan Asset Management: Life Sciences Innovation Summit

Entrepreneurs developing therapeutics are welcome to apply by visiting Lyfebulb.com
stage:
Won
prize:
Present your Pitch at the Summit in Abu Dhabi
more
Summary
Timeline
Forum
FAQ
Summary

Overview

J.P Morgan Life Sciences Private Capital and Blue Horizon Advisors are sponsoring the inaugural J.P. Morgan Asset Management: Life Sciences Innovation Summit at the Cleveland Clinic Abu Dhabi on May 14 – 15th, 2024. The inaugural event seeks to attract top caliber, early stage entrepreneurs in life sciences to seed the growth of the emerging scientific innovation hub in Abu Dhabi. The two-day Summit will take place in conjunction with the Abu Dhabi Global Healthcare Week.

The Summit aims to bring together the life sciences leaders of today and the leaders of tomorrow who are building a wide range of innovative therapeutic solutions for diseases prevalent in the Emirati region. Examples of these include, but are not limited to, diabetes, obesity, cardiometabolic disease, oncology, sickle cell anemia, cystic fibrosis, lysosomal storage disease, and rare monogenic disorders.

Upon review of applications, J.P. Morgan Life Sciences Private Capital and Blue Horizon Advisors will invite 10 emerging companies to pitch to an industry-renowned judging panel. All finalists will have the potential opportunity to gain support from J.P. Morgan Life Sciences Private Capital, Blue Horizon Advisors, and other prominent regional investors to fuel their growth.

 

APPLY by going to Lyfebulb.com


Eligibility

  • Companies seeking funding for innovative therapeutics
  • Any stage of therapeutic development
  • Open domicile: submissions from all countries welcome
  • Private, registered, for-profit companies (LLC, C-Corp, S-Corp, etc.)

Judging Criteria

Unmet Need

  • Strategic basis for addressing unmet needs of the patient population in the Emirati region
  • Target diseases include, but are not limited, to diabetes, obesity, cardiometabolic disease, oncology, sickle cell anemia, cystic fibrosis, lysosomal storage disease, and rare monogenic disorders

Impact

  • Potential of the innovation to improve patient outcomes

Market Feasibility

  • Differentiation strategy
  • Preliminary clinical development and regulatory strategy
  • Feasibility of development and implementation

Technology

  • Novelty of the technology
  • Relevant peer-reviewed scientific publications
  • Ability to protect the technology (i.e. IP)

Operations

  • Scalability
  • Organization expansion plans

What Happens After I Apply?

As previewed, after a 10-week application period and a thorough analysis by expert scientists and investors, 10 applicants will be shortlisted as finalists and will receive an invitation to pitch their ideas and therapeutic solutions over the course of a two-day summit in Abu Dhabi on May 14th–15th, 2024.

An expert panel of judges, as further described below, will assess the innovators.

The challenge is currently accepting applications through January 22, 2024. Finalists will be selected and notified in mid-February 2024.


Apply Now

Apply by visiting Lyfebulb.com

Timeline
Forum
FAQ